Robertson Bruce C reported grant involving 37,500 derivative units of EXAGEN INC. at $0.00 for $0 on Jun 9, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Aug 19, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
37,500Stock Option(right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
55,500Direct
Trade date
Jun 9, 2026Grant
Filed
Aug 19, 2026, 6:57 PM ET71-day reporting delay
Accession
0001274737-26-000056Code A · Transaction 12135
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 71 calendar days after the transaction date.

XGN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
XGN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −59%1w ago −28%1d ago −28%
Returns since7d +3.2%30d +13%90d180d1y

Footnotes in full

F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.